ANKRD36 and carcinoma: We found that every AML infant was a compound heterozygote for only two genes: MLL3 and ANKRD36. ANKRD36 (ankyrin repeat domain 36) was not a leukemia candidate gene and has not been previously associated to leukemia, albeit multiple carcinomas with somatic mutations have been identified in COSMIC.